Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Bayer HealthCare Pharmaceuticals INC
Homme Max 99 ans
Bayer HealthCare Pharmaceuticals INC
MAJ Il y a 5 ans
Trial to evaluate the effect of two treatment regimens for adults with severe hemophilia A
To evaluate the effects of secondary prophylaxis on bleeding frequency (number of all bleeds per year) compared to episodic treatment.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Bayer HealthCare Pharmaceuticals INC
MAJ Il y a 5 ans
A multicenter, randomized, double-blind, crossover, phase 3 study to determine the safety and efficacy of gadobutrol 1.0 molar (Gadovist®) in patients referred for contrast-enhanced MRI of the central nervous system (CNS)
Superiority of combined unenhanced and gadobutrol-enhanced magnetic resonance imaging (MRI) compared to unenhanced MRI based on the evaluation of the following: • Degree of contrast enhancement • As...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Bayer HealthCare Pharmaceuticals INC
MAJ Il y a 5 ans
Open-label, multi-center, two-stage, age stratified, pharmacokinetic, safety, and efficacy study in children 2 month to < 2 years of age undergoing Magnevist Injection enhanced MRI
Stage 1: To determine the optimal efficacious dose (0.05 mmol/kg or 0.1 mmol/kg BW) of Magnevist Injection Stage 2: To evaluate pharmacokinetics of Magnevist Injection at the optimal efficacious dos...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations